MileBot Robotics has raised $14.9M in new funding, a capital infusion that underscores the growing market for robotic rehabilitation technology. The company, which describes itself as a leading manufacturer of exoskeletal rehabilitation robots, is now positioned to scale its operations in a sector where demand is climbing as healthcare systems seek more automated therapy solutions.
The round’s backers were not disclosed, but the size of the raise signals meaningful investor confidence in the category. MileBot’s focus on exoskeletal devices-wearable robotics designed to assist patients with mobility recovery-places it in a niche that blends hardware engineering with clinical application. With this capital, the company has room to expand production or deepen its product pipeline, though specific plans were not detailed.
